Decoy Therapeutics Inc. is trading at $6.83 (+6.47%) in pre-market as the stock extends a recovery from its June 16 dilution-related decline.
- The stock was previously pressured by a resale filing for up to 808,000 common shares earlier this week.
- Broader market sentiment is also providing a tailwind, with U.S. futures and major indices trading higher this morning.